Regulus Therapeutics Announces Poster Presentation at ASN Kidney Week 2022

SAN DIEGO, Oct. 27, 2022 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the “Company” or “Regulus”), today announced a poster presentation at the American Society…

Click here to view original post